At the 2017 Medical Student Research Forum, aspiring physician-scientists showcased 46 original research projects they conducted at the University at Buffalo, its partner health care agencies and institutions nationwide.
Students from the Jacobs School of Medicine and Biomedical Sciences joined hundreds of their UB peers in the health professions, social work, law and management for an interprofessional forum on opioid dependence.
A new preclinical study by researchers in the Department of Pharmacology and Toxicology finds exercise, coupled with methamphetamine, may help recovery of those addicted to the drug and increase their odds of avoiding relapse.
A team led by David M. Dietz, PhD, has discovered that a protein in the brain’s reward center, the nucleus accumbens, regulates genes that help drive the craving for cocaine after a period of withdrawal.
Andrew H. Talal, MD, professor of medicine in the Division of Gastroenterology, Hepatology and Nutrition, has received a $7 million grant to develop an effective way to treat drug users with the hepatitis C virus (HCV).
Jun-Xu Li, MD, PhD, assistant professor of pharmacology and toxicology, has received the Joseph Cochin Young Investigator Award from the College of Problems of Drug Dependence (CPDD) for his research on pharmacotherapy for stimulant abuse.
Aspiring physician-scientists showcased 38 original research projects at the 2016 Medical Student Research Forum. The displays showed work they conducted at the University at Buffalo, its partner health care agencies and institutions nationwide.
The University at Buffalo is strengthening education for medical residents who care for patients who are addicted or are at risk for addiction by focusing more training on safe prescribing practices and safe pain management.
At the 2015 Medical Student Research Forum, aspiring physician-scientists showcased 45 original research projects they conducted at the University at Buffalo, its partner health care agencies and institutions nationwide.
Zhen Yan, PhD, professor of physiology and biophysics, has received $1.6 million to continue her study of human dopamine D4 receptor variants — a type of neurotransmitter receptor in the brain’s prefrontal cortex.
The risks of the new painkiller Zohydro — an extended-release formulation of hydrocodone — far outweigh the benefits and could lead to more overdoses, according to Richard D. Blondell, MD, vice chair for addiction medicine and professor of family medicine.